Report ID: SQMIG35J2075
Report ID:
SQMIG35J2075 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|
Tables:
71 |
Figures:
65
Cancer Pain Market size was valued at USD 6.92 Billion in 2023 and is poised to grow from USD 7.31 Billion in 2024 to USD 11.3 Billion by 2032, growing at a CAGR of 5.6% during the forecast period (2025-2032).
The expansion of the global cancer pain market is primarily propelled by factors including the growing cancer prevalence, an aging population, increased healthcare spending, and augmented research and development efforts by healthcare enterprises.
In 2020, for instance, the American Cancer Society reported approximately 1.8 million new cancer cases and around 606,520 cancer-related deaths in the U.S. Colorectal cancer saw about 1,065,960 new cases worldwide that same year, according to the International Agency for Research on Cancer.
Older individuals are more susceptible to various cancers due to age-related effects and genetic mutations. The National Cancer Institute indicates median diagnosis ages of 61 for breast cancer, 68 for colorectal cancer, 70 for lung cancer, and 66 for prostate cancer.
US Cancer Pain Market is poised to grow at a sustainable CAGR for the next forecast year.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35J2075